Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.43.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.50 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.50 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.50 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.50 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.266ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.266ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.266ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.266NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.253ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.253ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.253ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.253NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.305ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.305ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.305ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.305NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.1.241ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.241ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.241ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.241NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.326ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.326ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.326ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.326NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.255ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.255ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.255ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.255NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.303ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.303ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.303ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used